Pharmaceutical Industry Information Portal

HomeNews

News

Pfizer, Bayer keep supplying drugs to Russia

Pfizer Inc and Bayer said on Monday they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential spending...

Sanofi and Blackstone collaborate on 300 million euros to develop innovative treatment for multiple myeloma

Sanofi and Blackstone today announced a strategic, risk-sharing collaboration under which funds managed by Blackstone Life Sciences (BXLS) will contribute up to €300 million...

Sandoz bolsters respiratory ambitions with the acquisition of Coalesce

Sandoz, a Novartis division, announced today that it has successfully acquired the UK-based medical and drug delivery device development company, Coalesce Product Development Limited. Coalesce...

Novavax’s COVID vaccine is struggling to be rolled out in the EU

Demand for the COVID-19 vaccine produced by U.S. biotech firm Novavax has been underwhelming in the European Union's main countries in the early rollout,...

FDA declines to approve AstraZeneca treatment for chronic nasal condition

AstraZeneca Plc said on Monday the U.S. drug regulator declined to approve its asthma medicine, Fasenra, for treatment of chronic rhinosinusitis with nasal polyps,...

Pfizer completes acquisition of Arena Pharmaceuticals for $6.7 billion

Pfizer Inc. announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of...
spot_img

Expert Articles

spot_img